MENU
+Compare
AVTE
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$2.75
Change
+$0.07 (+2.61%)
Capitalization
79.71M

AVTE Aerovate Therapeutics Forecast, Technical & Fundamental Analysis

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease... Show more

AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AVTE with price predictions
Apr 16, 2025

AVTE in upward trend: price rose above 50-day moving average on April 07, 2025

AVTE moved above its 50-day moving average on April 07, 2025 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 10, 2025. You may want to consider a long position or call options on AVTE as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AVTE just turned positive on April 10, 2025. Looking at past instances where AVTE's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for AVTE crossed bullishly above the 50-day moving average on March 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for AVTE moved above the 200-day moving average on April 01, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVTE advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 149 cases where AVTE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVTE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVTE broke above its upper Bollinger Band on April 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.043) is normal, around the industry mean (13.662). P/E Ratio (0.000) is within average values for comparable stocks, (62.714). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.754). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (248.452).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVTE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVTE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AVTE is expected to report earnings to rise 117.52% to -41 cents per share on May 19

Aerovate Therapeutics AVTE Stock Earnings Reports
Q1'25
Est.
$-0.41
Q4'24
Beat
by $0.21
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.07
The last earnings report on March 26 showed earnings per share of -18 cents, beating the estimate of -40 cents. With 178.11K shares outstanding, the current market capitalization sits at 79.71M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
930 Winter Street
Phone
+1 617 443-2400
Employees
51
Web
https://www.aerovatetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

AVTE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
+2.61%
OVID - AVTE
89%
Closely correlated
+6.53%
NTLA - AVTE
47%
Loosely correlated
+5.39%
DNLI - AVTE
43%
Loosely correlated
+1.51%
BEAM - AVTE
41%
Loosely correlated
+2.29%
SNDX - AVTE
39%
Loosely correlated
+4.43%
More

Groups containing AVTE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
+2.61%
AVTE
(2 stocks)
100%
Closely correlated
+4.57%